By Fraiser Kansteiner
A former Novartis sales representative has accused the company and two of her former supervisors of wrongfully firing her after she blew the whistle on a co-worker who allegedly falsified records.
read more
By Andrea Park
Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective.
read more
Sponsored By: Parexel
The rise of clinical trial complexity has been well-documented but the impact on logistics is not well understood. Here, we look at decentralized trials, patient experience and the role of logistics.
read more
By Max Bayer
Zymeworks is shifting its corporate home base from Canada to tax-friendly Delaware in a bid to reduce costs. The move is expected to be finalized in the fourth quarter.
read more
By Nick Paul Taylor
AbbVie has helped Oncternal Therapeutics move a step closer to a phase 3 trial by agreeing to supply the Bruton’s tyrosine kinase inhibitor ibrutinib for use in the study.
read more
By Conor Hale
Speeding up a brain scan could be especially useful in examining young children with hydrocephalus, which accounts for more than 40,000 hospital visits annually, the company said.
read more
By Andrea Park
After securing FDA clearance for its flagship digital therapeutic, there’s no need for Akili Interactive to completely reinvent the wheel to develop its future offerings.
read more
By James Waldron
Many companies like to talk big about how hot the startup scene is in Asia, but Merck KGaA is putting its money where its mouth is. The German drugmaker is offering funding of up to $100,000 to startups across the region that can impress it with their vision.
read more
By Zoey Becker
Come Monday, GSK and consumer health unit Haleon will officially part ways, leaving the Big Pharma's biopharma and vaccines divisions to stand on their own. Will CEO Emma Walmsley reach for new M&A?
read more
By Fraiser Kansteiner
While reimbursement and education challenges persist, drugmakers like Eli Lilly and Novo Nordisk are poised to unlock a global obesity market that could be worth more than $50 billion by the end of the decade, analysts at Morgan Stanley Research wrote in a note to clients Friday.
read more
By Robert King
Most health insurers have been complying with a new regulation to post a trove of data on their rates, and experts are detailing how they plan to use it.
read more
By Dave Muoio
Although deal volume remains muted, a small handful of big-ticket deals and a single megamerger will have plenty of money changing hands, Kaufman Hall wrote in a new hospital and health system transaction report.
read more
Sponsored by: Cognizant
Explore how Cognizant SIP helped Roche streamline its global feasibility process.
Sponsored by: Blue Matter Consulting
For an emerging biopharma company, Europe can be very attractive. But it can also be complex and confusing. This e-book covers the 12 most common pitfalls for companies entering European markets for the first time, offering guidance to help growing companies avoid them and succeed.
Sponsored by: CG Life
Explore the new cell therapy handbook from Thermo Fisher Scientific.
Sponsored by: Catalent
What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations?
Sponsored by: Thermo Fisher Scientific
Sponsored by Thermo Fisher Scientific The journey for starting or expanding a lab can be exhilarating, while also being challenging--learn how this free program provides savings and solutions to support your goals.
Sponsored by: Catalent
Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
Sponsored by: Catalent
What are key considerations for intranasal delivery in the treatment of acute and chronic conditions?
